tradingkey.logo
tradingkey.logo
Search

Moderna Inc

MRNA
Add to Watchlist
254.190USD
+12.730+5.27%
Close 11-05 16:00(ET)
101.48BMarket Cap
LossP/E TTM
After-hours 16:10 (ET)255.300USD+1.490+0.59%

Moderna Inc Earnings Dates & Reports

This page offers detailed Moderna Inc earnings data including the latest Moderna Inc earnings report, the upcoming Moderna Inc earnings date, historical data and Moderna Inc earnings call news.

MRNA Latest Quarter’s Earnings
Announce Date11/6/2026
EPS Actual (USD)--
Revenue Actual (USD)--
MRNA Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
MRNA FY2025 Earnings
EPS (YoY)-7.2521.77%
Revenue (YoY)1.94B-39.93%

Moderna Inc (MRNA) Earnings History

Release DatePeriod EndEPS/ForecastRevenue/ForecastEPS Surprise %Revenue Surprise %
7/31/202606/2026-1.96/-2.08145.00M/103.00M5.68%40.78%
5/1/202603/2026-3.40/-3.96389.00M/227.97M14.16%70.64%
2/13/202612/2025-2.11/-2.64678.00M/626.10M20.26%8.29%
11/6/202509/2025-0.51/-2.111.02B/886.54M75.66%14.60%
8/1/202506/2025-2.13/-2.97142.00M/112.94M28.32%25.73%
5/1/202503/2025-2.52/-3.14108.00M/106.20M19.79%1.70%
2/14/202512/2024-2.89/-2.68966.00M/942.84M-7.79%2.46%
11/7/202409/20240.03/-1.911.86B/1.25B101.77%48.94%

Moderna Inc Latest Earnings Call Transcripts

Moderna (MRNA) Q3 2026 Earnings Call: Revenue Up 29%, Outlook Raised

Moderna’s Q3 2026 earnings call covered 29% revenue growth, positive Phase III intismeran data, stronger cash levels and raised full-year guidance.

FAQs

How did Moderna Inc perform in its last earnings report?

On 2026-07-31, Moderna Inc reported EPS of -1.96 and +5.68% EPS surprise. Revenue was 145.00M, compared with the consensus estimate of 103.00M.

What does an earnings surprise mean?

An earnings surprise is the difference between a company's reported EPS or revenue and the analysts' consensus estimate. A positive surprise means results exceeded expectations, while a negative surprise means results fell short.

How can earnings reports affect MRNA stock?

Earnings reports can increase volatility in MRNA stock, especially when reported EPS, revenue or company guidance differs from market expectations. An earnings beat does not always lead to a price increase, as investors also consider the outlook, valuation and broader market conditions.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.